Navigation Links
Dr. Ben Goldacre to Keynote PhUSE Annual Conference
Date:2/7/2013

Brussels, Belgium (PRWEB) February 07, 2013

PhUSE, a non-profit, volunteer-supported, community of professionals who are passionate about advancement of clinical information, is proud to announce that Dr. Ben Goldacre will present the Keynote at the 2013 PhUSE Annual Conference. The 2013 conference focus is ‘Patient Centricity’ in the pharmaceutical world.

As a physician and academic writer Doctor Ben Goldacre will speak to the PhUSE community about how patient centric thinking will help to bring efficacious new drugs to patients. In his latest book "Bad Pharma" Doctor Ben Goldacre gives a critical insight into the 600 billion dollar global pharmaceutical industry. In his keynote Doctor Goldacre will share his views on the process of new drug approval. He will tell the PhUSE community how flaws in the planning, conduct and publication of studies conducted by the pharmaceutical industry can harm the life of patients.

In his keynote for PhUSE, Doctor Goldacre will address the interests of all involved parties: the patients, pharmaceutical drug companies, regulatory bodies and payers.

Discussion groups for conference attendees will expand upon the themes of the keynote, giving attendees the opportunity to learn and share knowledge about creating better outcomes for patients through their work with clinical trial data.

Registration for the conference is open. Sponsorship opportunities are available.

About Doctor Goldacre:
Ben Goldacre is an award-winning writer, broadcaster, and medical doctor who specializes in unpicking scientific claims made by scaremongering journalists, government reports, pharmaceutical corporations, PR companies and quacks. He was trained in Medicine at Oxford and London, and currently works as an academic in epidemiology. Ben wrote the weekly Bad Science column in the Guardian from 2003-2011. Bad Science the book (4th Estate) has sold over half a million copies worldwide, reached #1 in the paperback non-fiction charts, and is being published in 25 languages. In his new book, Bad Pharma (4th Estate, September 2012) Ben puts the $600bn global pharmaceutical industry under the microscope. What he reveals is a fascinating, terrifying mess.

About PhUSE
PhUSE, Share – Contribute – Advance, provides the industry with the premier platform for creating and sharing ideas, tools and standards around data, statistical and reporting technologies; PhUSE is a non-profit, volunteer-supported, community of professionals who are passionate about advancement of clinical information. Since its inception, PhUSE has expanded from its roots as a conference for European Statistical Programmers, to a global platform for the discussion of topics encompassing the work of Data Managers, Biostatisticians, Statistical Programmers and eClinical IT professionals.

Read the full story at http://www.prweb.com/releases/BenGoldacre/PhUSEAnnualConference/prweb10400642.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium
2. Specialty Chemical Forum 2012 Kicks Off in Houston; AkzoNobels Frank Sherman Delivers Keynote Address
3. National Defense Industrial Association's (NDIA) 2012 Biosurveillance Conference To Feature Keynote Speaker Laurie Garrett, Pulitzer Prize Winner and Bestselling Author
4. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
5. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
6. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
7. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
8. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
9. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
10. 15-Minute Data From Phase 3 Study of Avanafil Featured as a Late Breaking Abstract at SMSNA Annual Meeting
11. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Houston Methodist Willowbrook ... Cy-Fair Sports Association to serve as their official ... Houston Methodist Willowbrook will provide sponsorship support, athletic ... with association coaches, volunteers, athletes and families. ... Cy-Fair Sports Association and to bring Houston Methodist ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... , ... June 23, 2016 , ... STACS DNA Inc., ... Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field ... DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding ...
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a company ... to the medical community, has closed its Series A ... Nunez . "We have received a commitment ... capital we need to meet our current goals," stated ... us the runway to complete validation on the current ...
Breaking Biology Technology:
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
Breaking Biology News(10 mins):